+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Insulin"

From
From
From
Empagliflozin Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

Empagliflozin Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
From
PRV-031 Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

PRV-031 Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
RYZODEG Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

RYZODEG Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
LEVEMIR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LEVEMIR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Lipodystrophy - Epidemiology Forecast - 2032 - Product Thumbnail Image

Lipodystrophy - Epidemiology Forecast - 2032

  • Report
  • February 2023
  • 50 Pages
  • Global
From
Smart Insulin Pens Market - Product Thumbnail Image

Smart Insulin Pens Market

  • Report
  • March 2024
  • 200 Pages
  • Global
From
From
Global Markets for Diabetes Therapeutics and Diagnostics - Product Thumbnail Image

Global Markets for Diabetes Therapeutics and Diagnostics

  • Report
  • August 2023
  • 336 Pages
  • Global
From
Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
Non-Injectable Insulin - Product Thumbnail Image

Non-Injectable Insulin

  • Report
  • January 2020
  • 54 Pages
  • Global
From
From
Type 1 Diabetes Market Report and Forecast 2025-2034 - Product Thumbnail Image

Type 1 Diabetes Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
GLP-1 Agonists Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

GLP-1 Agonists Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Goiter Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Goiter Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Loading Indicator

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more